INTRODUCTION: Important clinical and epidemiological changes have been observed in lung cancer (LC) in our healthcare area compared to the previous decade. In the last 10 years, specific LC care circuits have been implemented and the active search for cases has been stepped up. The aim of this study was to analyze the progress of these changes over the last 20 years. METHODS: This is a retrospective study comparing clinical and epidemiological changes between 2 historical cohorts of LC patients (1992-1994 [group 1, 164 patients] and 2004-2006 [group 2, 250 patients]) and a current group from the period 2011-2012 (group 3, 209 patients) RESULTS: Two hundred and nine (209) LC patients were included in group 3 (2011-2012 period). After comparing groups 3 and 2, a non-significant rise in smoking was observed in women (59% vs 41%, p=.25), while the prevalence of adenocarcinoma was unchanged (45% vs 44%, p=.9). The main changes observed were the increase in cases with previous malignancies (23% vs 16%, p=.04), the rise in patients with no associated LC symptoms (33% vs 16%, p<.001), and an increased number of localized NSCLC (non-small cell LC) diagnoses (42% vs 24% in series 2, p<.001 and 14.2% in series 1, p<.001). CONCLUSIONS: The number of LC patients diagnosed in localized stages has increased significantly. Furthermore, the number of patients with no symptoms associated with LC and with a history of previous malignancy were significantly increased.
INTRODUCTION: Important clinical and epidemiological changes have been observed in lung cancer (LC) in our healthcare area compared to the previous decade. In the last 10 years, specific LC care circuits have been implemented and the active search for cases has been stepped up. The aim of this study was to analyze the progress of these changes over the last 20 years. METHODS: This is a retrospective study comparing clinical and epidemiological changes between 2 historical cohorts of LC patients (1992-1994 [group 1, 164 patients] and 2004-2006 [group 2, 250 patients]) and a current group from the period 2011-2012 (group 3, 209 patients) RESULTS: Two hundred and nine (209) LC patients were included in group 3 (2011-2012 period). After comparing groups 3 and 2, a non-significant rise in smoking was observed in women (59% vs 41%, p=.25), while the prevalence of adenocarcinoma was unchanged (45% vs 44%, p=.9). The main changes observed were the increase in cases with previous malignancies (23% vs 16%, p=.04), the rise in patients with no associated LC symptoms (33% vs 16%, p<.001), and an increased number of localized NSCLC (non-small cell LC) diagnoses (42% vs 24% in series 2, p<.001 and 14.2% in series 1, p<.001). CONCLUSIONS: The number of LC patients diagnosed in localized stages has increased significantly. Furthermore, the number of patients with no symptoms associated with LC and with a history of previous malignancy were significantly increased.
Authors: Mercè Mateu-Jiménez; Albert Sánchez-Font; Alberto Rodríguez-Fuster; Rafael Aguilό; Lara Pijuan; Clara Fermoselle; Joaquim Gea; Victor Curull; Esther Barreiro Journal: Mol Med Date: 2016-01-07 Impact factor: 6.354
Authors: Alberto Caballero Vázquez; Paula García Flores; Ana Romero Ortiz; Raimundo García Del Moral; Bernardino Alcázar-Navarrete Journal: J Thorac Dis Date: 2018-09 Impact factor: 2.895
Authors: Cecilia Mouronte-Roibás; Alberto Fernández-Villar; Alberto Ruano-Raviña; Cristina Ramos-Hernández; Amara Tilve-Gómez; Paula Rodríguez-Fernández; Adriana Carolina Caldera Díaz; Míriam García Vázquez-Noguerol; Sara Fernández-García; Virginia Leiro-Fernández Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-10-29
Authors: Cecilia Mouronte-Roibás; Virginia Leiro-Fernández; Alberto Ruano-Raviña; Cristina Ramos-Hernández; Pedro Casado-Rey; Maribel Botana-Rial; Esmeralda García-Rodríguez; Alberto Fernández-Villar Journal: Respir Res Date: 2019-08-28
Authors: Anna Salazar-Degracia; David Blanco; Mònica Vilà-Ubach; Gabriel de Biurrun; Carlos Ortiz de Solórzano; Luis M Montuenga; Esther Barreiro Journal: J Transl Med Date: 2016-08-23 Impact factor: 5.531
Authors: Virginia Leiro-Fernández; Cecilia Mouronte-Roibás; Esmeralda García-Rodríguez; Maribel Botana-Rial; Cristina Ramos-Hernández; María Torres-Durán; Alberto Ruano-Raviña; Alberto Fernández-Villar Journal: Thorac Cancer Date: 2019-01-03 Impact factor: 3.500